University Hospital Düsseldorf
University Hospital Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GRAnulomatous MAstitis REGistry Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, breast disorder, cystic fibrosis, granulomatous mastitis, hereditary disease, lung disorder, mastitis, pancreas disorder, pregnancy disorder, puerperal disorder, respiratory system disorder, skin disorder | Recruiting | Not stated | 2026-09-15 | NCT07422870 | |
| Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-08-27 | NCT07655479 | |
| Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, testicular cancer, testicular disorder, testicular germ cell tumor | Not yet recruiting | Not applicable | 2026-07-13 | NCT07699640 | |
| Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Not stated | 2026-06-10 | NCT07273903 | |
| PROCARE - PROstate Cancer Real World Evidence Registry | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not stated | 2026-03-12 | NCT06835218 | |
| Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-03-06 | NCT03947619 | |
| Biological Determinants and Neural Compensation of Dysphagia in Parkinson's Disease | Deglutition Disorders, Digestive System Diseases, Oropharyngeal Dysphagia, Parkinson disease, Pharyngeal Diseases, basal ganglia disorder, brain disorder, central nervous system disorder, digestive system disorder, esophageal disorder, movement disorder, nervous system disorder, neurodegenerative disease, otorhinolaryngologic disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2025-12-23 | NCT07299448 | |
| GEL & MEDication Dysphagia | Healthy Participants; Neurological Diseases or Conditions | Recruiting | Not stated | 2025-11-28 | NCT07254663 | |
| Adaptation and Validation of a Patient-centered Outcome Scale for People in the Intensive Care Unit (IPOS-ICU) | Intensive Care Unit Patients | Not yet recruiting | Not stated | 2025-06-04 | NCT07004920 | |
| Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2024-05-07 | NCT05033756 |